Metraipolis › archive › dc_ff62923e2443

CRISPR-Cas9 Therapeutics in Early Clinical Development: Delivery and Molecular Diagnostics — Europe PMC PMID:41972732

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41972732
DOI
10.3390/cells15070644
License (as archived)
solo-consultazione
Archived
2026-11-03T10:07:35.574Z
SHA-256 of the archived text
f19ea512c19c1e59daaf9b174af0192a75430acb236b1c4b05c6f9fba6edcc5b
Stable URL of this page
https://metraipolis.com/documento/dc_ff62923e2443

How to cite

CRISPR-Cas9 Therapeutics in Early Clinical Development: Delivery and Molecular Diagnostics — Europe PMC PMID:41972732 — Europe PMC (en), https://europepmc.org/article/MED/41972732 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff62923e2443 (Metraipolis archive dc_ff62923e2443, sha256 f19ea512c19c1e59daaf9b174af0192a75430acb236b1c4b05c6f9fba6edcc5b)
BibTeX
@misc{dcff62923e2443,
  title = {CRISPR-Cas9 Therapeutics in Early Clinical Development: Delivery and Molecular Diagnostics — Europe PMC PMID:41972732},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41972732},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff62923e2443; sha256 f19ea512c19c1e59daaf9b174af0192a75430acb236b1c4b05c6f9fba6edcc5b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41972732. Agents can read the archived copy with the MCP tool read_document.